scispace - formally typeset
F

Feng Shen

Researcher at Second Military Medical University

Publications -  403
Citations -  12498

Feng Shen is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 46, co-authored 313 publications receiving 8315 citations.

Papers
More filters
Journal ArticleDOI

Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.

TL;DR: A high preoperative hepatitis B virus (HBV) DNA load was an independent hepatitis-related risk for both early and late recurrence, and early recurrence was associated with worse postrecurrence survival among patients with recurrence.
Journal ArticleDOI

Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts.

TL;DR: It is reported that high levels of cholesterol predict good survival and low disease recurrence after surgery and pharmacologically promoting CD44 retention inside lipid rafts obviously attenuated HCC migration and invasion, providing a potential therapeutic strategy to prolong the survival of HCC patients.
Journal ArticleDOI

Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.

TL;DR: The results indicated that the serum expression of uc001ncr and AX800134 has potential as novel potential biomarker for the diagnosis of HCC, especially in patients with AFP≤400 ng/ml or early-stage disease (BCLC 0+A).
Journal ArticleDOI

A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy.

TL;DR: The nomogram was accurate in predicting PM following curative hepatectomy for HCC and demonstrated positive net benefits by the nomogram, within the threshold probabilities of PM >10%.